NCT06996782 A Platform Study in Non-Small Cell Lung Cancer (NSCLC) Status RECRUITING Phase PHASE1/PHASE2
NCT05450692 A Phase III Study of Ceralasertib Plus Durvalumab Versus Docetaxel in Patients With Non Small Cell Lung Cancer (NSCLC) Whose Disease Progressed On or After Prior Anti PD (L)1 Therapy And Platinum Based Chemotherapy Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05388669 A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced or Metastatic Non-small Cell Lung Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3